Post-thrombotic syndrome in children with symptomatic deep vein thrombosis
- Authors: Yafoshkina T.Y.1, Levin P.A.1, Zharkov P.A.1
-
Affiliations:
- The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
- Issue: Vol 23, No 3 (2024)
- Pages: 130-137
- Section: ORIGINAL ARTICLES
- Submitted: 05.12.2023
- Accepted: 11.01.2024
- Published: 08.07.2025
- URL: https://hemoncim.com/jour/article/view/783
- DOI: https://doi.org/10.24287/1726-1708-2024-23-3-130-137
- ID: 783
Cite item
Full Text
Abstract
Deep vein thrombosis (DVT) is an increasingly common diagnosis in pediatric inpatients. Approximately 85% of DVTs of extremities are associated with the use of a central venous catheter (CVC). CVC-related thrombosis and non-CVC-related thrombosis differ in their pathophysiology and patient characteristics. We thought it worthwhile to try and analyze whether there was an association between these parameters and further development of complications, namely, post-thrombotic syndrome (PTS). Thus, we aimed to evaluate differences in patient characteristics as well as in the frequency and severity of PTS in children with symptomatic CVC-related and non-CVC-related thrombosis. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. We retrospectively analyzed medical records of patients aged 0 to 18 years (at the time of thrombosis) who had undergone treatment at the Center between 2013 and 2023 and selected patients with verified symptomatic DVT of the upper or lower extremity. The patients were divided into 2 groups: patients with CVC-related thrombosis (group 1) and patients with non-CVC-related thrombosis (group 2). Then we analyzed data on PTS in these patients collected during consultations with a hematologist at the Center or via a phone interview. PTS was evaluated using the Russian versions of the Manco–Johnson Instrument (MJI), the Modified Villalta Scale (MVS) and the Clinical Assessment of PTS (CAPTSure) (see the supplementary materials). The statistical significance of differences between the groups was assessed using Chi-square test or, if the expected values in a table were less than 5, using Fisher’s exact test. The study included 47 patients with symptomatic DVT: 17 patients with CVC-related DVT and 30 patients with non-CVCrelated DVT. The patients with CVC-related DVT were found to be younger at the time of thrombosis (median age: 4.1 years (range: 0–17 years) in group 1 versus 15.5 years (range: 3–17 years) in group 2; р < 0.001) and were followed up for longer periods of time (median follow-up time: 5 years (range: 0.5–15 years) in group 1 versus 1 year (range: 0.5–7.5 years) in group 2; р = 0.001). Recanalization at 3 months after DVT was better in the patients with non-CVC-related DVT (50% of the patients in group 1 versus 93% of the patients in group 2; р = 0.002). The overall frequency of PTS was 87% in accordance with MVS/ MJI and 68% as per CAPTSure. The frequency of PTS in the groups was comparable: there were 13 (76%) patients with PTS in the CVC-related thrombosis group and 28 (93%) patients in the non-CVC-related thrombosis group; р = 0.2). The patients with non-CVC-related DVT were found to have more severe PTS more often: 44% of the patients with moderate PTS in the non-CVCrelated DVT group versus 23% of the patients with moderate PTS and CVC-related DVT; р = 0.2. However, these differences did not turn out to be statistically significant. Thus, there were no statistically significant differences in either the frequency or severity of PTS between the two groups. In this study, the overall frequency of PTS in the patients with symptomatic DVT was rather high but the majority of the children in both groups had mild PTS. Still, since PTS is a late complication, it is important to continue patient follow-up to monitor symptoms and severity of chronic venous insufficiency over time.
About the authors
T. Yu. Yafoshkina
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Author for correspondence.
Email: yafoshkina.tatyana@gmail.com
ORCID iD: 0000-0003-2719-1233
PhD student, hematologist at outpatient unit.
Moscow
Russian FederationP. A. Levin
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Email: pavel.levin@fccho-moscow.ru
ORCID iD: 0000-0002-2410-1223
Leading Researcher at the Information and Analytics Department.
Moscow
Russian FederationP. A. Zharkov
The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Email: pzharkoff@gmail.com
ORCID iD: 0000-0003-4384-6754
PhD, hematologist at outpatient unit, the head of Hemostasis Pathology Unit.
Moscow
Russian FederationReferences
- O'Brien S.H., Stanek J.R., Witmer C.M., Raffini L. The Continued Rise of Venous Thromboembolism Across US Children's Hospitals. Pediatrics 2022; 149 (3): e2021054649. doi: 10.1542/peds.2021-054649
- Avila L., Amiri N., De R., Vincelli J., Pullenayegum E., Williams S., et al. Characteristics of upperand lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children. Blood Adv 2021; 5 (19): 3737–47. DOI: https://doi.org/10.1182/bloodadvances.2021004727
- Betensky M., Goldenberg N.A. Post-thrombotic syndrome in children. Thromb Res 2018; 164: 129–35. doi: 10.1016/j.thromres.2017.07.024
- Kahn S.R., Comerota A.J., Cushman M., Evans N.S., Ginsberg J.S., Goldenberg N., et al.; American Heart Association Council on Peripheral Vascular Disease, Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association Circulation 2014; 130 (18): 1636–61.
- [Electronic resource] URL: https://www.who.int/tools/growth-reference-data-for-5to19-years/indicators/bmi-for-age (accessed 05.12.2023).
- [Electronic resource] URL: https:// www.who.int/toolkits/child-growthstandards/standards/bodymassindex-for-age-bmi-for-age (accessed 05.12.2023).
- Peterkova V.A., Bezlepkina O.B., Bolotova N.V., Bogova E.A., Vasyukova O.V., Girsh Ya.V., et al. Obesity in children: Clinical guidelines. Problems of Endocrinology 2021; 67 (5): 67–83. (In Russ.). doi: 10.14341/probl12802
- Dedov I.I., Mokrysheva N.G., Mel’nichenko G.A., Troshina E.A., Mazurina N.V., Ershova E.V., et al. Obesity: Clinical guidelines. Consilium Medicum 2021; 23 (4): 311–25. (In Russ.).
- Manco-Johnson M.J., Knapp-Clevenger R., Miller B.I., Hays T. Post-thrombotic syndrome (PTS) in children: validation of a new pediatric outcome instrument and results in a comprehensive cohort of children with extremity deep vein thrombosis (DVT). Blood 2003; 102: 553a.
- Kuhle S., Koloshuk B., Marzinotto V., Bauman M., Massicotte P., Andrew M., et al. A crosssectional study evaluating postthrombotic syndrome in children, Thromb Res 2003; 111 (4–5): 227–33. DOI: https://doi.org/10.1016/j.thromres.2003.09.008.
- Avila M.L., Feldman B.M., Pullenayegum E., Lumia C., Montoya M.I., Vincelli J., et al. Post-thrombotic syndrome in children: Measurement properties of CAPTSure, a new diagnostic tool. Res Pract Thromb Haemost 2019; 3 (4): 652–7. doi: 10.1002/rth2.12251
- Tuckuviene R., Christensen A.L., Helgestad J., Johnsen S.P., Kristensen S.R. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr 2011; 159 (4): 663–9. doi: 10.1016/j.jpeds.2011.03.052
- Whitworth H., Clark H.H., Hubbard R.A., Witmer C., Leonard C.E., Raffini L. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism. J Thromb Haemost 2023; 21 (1): 47–56. doi: 10.1016/j.jtha.2022.11.031
- [Electronic resource] URL: https:// www.uptodate.com/contents/venousthrombosis-and-thromboembolismvte-in-children-risk-factors-clinicalmanifestations-and-diagnosis (accessed 05.12.2023).
- Kahn S.R., Shrier I., Julian J.A., Ducruet T., Arsenault L., Miron M.J., et al. Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis. Ann Intern Med 2008; 149: 698–707. doi: 10.7326/0003-4819-149-10-200811180-00004
- Tick L.W., Kramer M.H., Rosendaal F.R., Faber W.R., Doggen C.J. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost 2008; 6 (12): 2075–81.
- Kreuz W., Stoll M., Junker R., Heinecke A., Schobess R., Kurnik K., et al. Familial elevated factor VIII in children with symptomatic venous thrombosis and post-throm-botic syndrome: results of a multicenter study. Arterioscler Thromb Vasc Biol 2006; 26 (8): 1901–6. doi: 10.1161/01.ATV.0000227510.36653.ed
- Betensky M., Amankwah E.K., Brandal S., Everett A.D., Goldenberg N.A. Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT Biobank. Blood Adv 2021; 5 (1): 233–9. doi: 10.1182/bloodadvances.2020002974
- Kumar R., Rodriguez V., Matsumoto J.M., Khan S.P., Weaver A.L., McBane R.D., et al. Prevalence and risk factors for post thrombotic syndrome after deep vein thrombosis in children: a cohort study. Thromb Res 2015; 135 (2): 347–51. doi: 10.1016/j.thromres.2014.12.005
- Goldenberg N.A., Donadini M.P., Kahn S.R., Crowther M., Kenet G., Nowak-Göttl U., et al. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 2010; 95 (11): 1952–9. doi: 10.3324/haematol.2010.026989
- O’Brien S.H., Zia A. Hemostatic and thrombotic disorders in the pediatric patient. Blood 2022; 140 (6): 533–41.
- Ginsberg J.S., Hirsh J., Julian J., Vander Laande Vries M., Magier D., MacKinnon B., et al.. Prevent Coagul Fibrinolysis 2009; 20 (7): 583–9. doi: 10.1097/MBC.0b013e32832ff577
- [Electronic resource] URL: www.uptodate.com:post-thrombion and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med 2001; 161 (17): 2105–9. doi: 10.1001/archinte.161.17.2105
- Tousovska K., Zapletal O., Skotakova J., Bukac J., Sterba J. Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy. Bloodotic (postphlebitic) syndrome. (accessed 05.12.2023).
- Kumar R., Rodriguez V., Matsumoto J.M., Khan S.P., Weaver A.L., McBane R.D., et al. Health-related quality of life in children and young adults with post-thrombotic syndrome: results from a cross-sectional study. Pediatr Blood Cancer 2014; 61 (3): 546–51. doi: 10.1002/pbc.24840
Supplementary files
